{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:10:18Z","timestamp":1792019418379,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,20]],"date-time":"2016-11-20T00:00:00Z","timestamp":1479600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,20]],"date-time":"2016-11-20T00:00:00Z","timestamp":1479600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81441022"],"award-info":[{"award-number":["81441022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670574"],"award-info":[{"award-number":["81670574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Tianjin, China","award":["11JCZDJC27800"],"award-info":[{"award-number":["11JCZDJC27800"]}]},{"name":"Natural Science Foundation of Tianjin, China","award":["12JCZDJC25200"],"award-info":[{"award-number":["12JCZDJC25200"]}]},{"name":"Technology Foundation of Health Bureau in Tianjin, China","award":["2011KY11"],"award-info":[{"award-number":["2011KY11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We determined whether bone marrow mesenchymal stem cells (BMMSCs) transduced with heme oxygenase-1 (HO-1), a cytoprotective and immune-protective factor, could improve outcomes for small bowel transplantation (SBTx) in rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed heterotopic SBTx from Brown Norway rats to Lewis rats, before infusing Ad\/HO-1-transduced BMMSCs (Ad\/HO-1\/BMMSCs) through the superficial dorsal veins of the penis. Respective infusions with Ad\/BMMSCs, BMMSCs, and normal saline served as controls. The animals were sacrificed after 1, 5, 7, or 10\u00a0days. At each time point, we measured small bowel histology and apoptosis, HO-1 protein and mRNA expression, natural killer (NK) cell activity, cytokine concentrations in serum and intestinal graft, and levels of regulatory T (Treg) cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The saline-treated control group showed aggravated acute cellular rejection over time, with mucosal destruction, increased apoptosis, NK cell activation, and upregulation of proinflammatory and immune-related mediators. Both the Ad\/BMMSC-treated group and the BMMSC-treated group exhibited attenuated acute cellular rejection at an early stage, but the effects receded 7\u00a0days after transplantation. Strikingly, the Ad\/HO-1\/BMMSC-treated group demonstrated significantly attenuated acute cellular rejection, reduced apoptosis and NK cell activity, and suppressed concentrations of inflammation and immune-related cytokines, and upregulated expression of anti-inflammatory cytokine mediators and increased Treg cell levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data suggest that Ad\/HO-1-transduced BMMSCs have a reinforced effect on reducing acute rejection and protecting the outcome of SBTx in rats.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-016-0427-8","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T13:40:55Z","timestamp":1479130855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats"],"prefix":"10.1186","volume":"7","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Nan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,20]]},"reference":[{"key":"427_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMra0804605","volume":"361","author":"TM Fishbein","year":"2009","unstructured":"Fishbein TM. Intestinal transplantation. N Engl J Med. 2009;361:998\u20131008.","journal-title":"N Engl J Med"},{"key":"427_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1600-6143.2009.03057.x","volume":"10","author":"S Pondrom","year":"2010","unstructured":"Pondrom S, The AJT. Report. Survival rates increase in bowel transplantation: seldom-done procedure comes of age. Am J Transplant. 2010;10:438\u201340.","journal-title":"Am J Transplant"},{"key":"427_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1432-2277.2008.00785.x","volume":"22","author":"KM Abu-Elmagd","year":"2009","unstructured":"Abu-Elmagd KM, Costa G, Bond GJ, Wu T, Murase N, Zeevi A, Simmons R, Soltys K, Sindhi R, Stein W, Demetris A, Mazariegos G. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int. 2009;22:96\u2013109.","journal-title":"Transpl Int"},{"key":"427_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/TP.0b013e3182145306","volume":"91","author":"A Webber","year":"2011","unstructured":"Webber A, Hirose R, Vincenti F. Novel strategies in immunosuppression: issues in perspective. Transplantation. 2011;91:1057\u201364.","journal-title":"Transplantation"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Huang X, Wang H, Liu X, Zhang T, Wang Y, Hu D. The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Res Ther. 2015;6:234.","journal-title":"Stem Cell Res Ther"},{"key":"427_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.12659\/MSM.897044","volume":"22","author":"C Wang","year":"2016","unstructured":"Wang C, Meng H, Wang X, et al. Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit. 2016;22:226\u201333.","journal-title":"Med Sci Monit"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"13149","DOI":"10.1038\/srep13149","volume":"5","author":"Y Li","year":"2015","unstructured":"Li Y, Ramcharan M, Zhou Z, et al. The role of scleraxis in fate determination of mesenchymal stem cells for tenocyte differentiation. Sci Rep. 2015;5:13149.","journal-title":"Sci Rep"},{"key":"427_CR8","first-page":"41","volume":"9","author":"S Chen","year":"2016","unstructured":"Chen S, Zhang W, Wang JM, et al. Differentiation of isolated human umbilical cord mesenchymal stem cells into neural stem cells. Int J Ophthalmol. 2016;9:41.","journal-title":"Int J Ophthalmol"},{"key":"427_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biopha.2016.01.020","volume":"78","author":"Z Ruan","year":"2016","unstructured":"Ruan Z, Zhu L, Yin Y, et al. Overexpressing NKx2. 5 increases the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyocyte-like cells. Biomed Pharmacother. 2016;78:110\u20135.","journal-title":"Biomed Pharmacother"},{"key":"427_CR10","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3892\/mmr.2015.3632","volume":"12","author":"P Gao","year":"2015","unstructured":"Gao P, Yang J, Gao X, et al. Salvianolic acid B improves bone marrow-derived mesenchymal stem cell differentiation into alveolar epithelial cells type I via Wnt signaling. Mol Med Rep. 2015;12:1971\u20136.","journal-title":"Mol Med Rep"},{"key":"427_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Teo GSL. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206\u201316.","journal-title":"Cell Stem Cell"},{"key":"427_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.imlet.2015.06.019","volume":"168","author":"AS Cornelissen","year":"2015","unstructured":"Cornelissen AS, Maijenburg MW, Nolte MA, et al. Organ-specific migration of mesenchymal stromal cells: who, when, where and why? Immunol Lett. 2015;168:159\u201369.","journal-title":"Immunol Lett"},{"key":"427_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1703","volume":"14","author":"R Sackstein","year":"2008","unstructured":"Sackstein R, Merzaban JS, Cain DW, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med. 2008;14:181\u20137.","journal-title":"Nat Med"},{"key":"427_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/scd.2006.15.79","volume":"15","author":"H Zhou","year":"2006","unstructured":"Zhou H, Ramiya VK, Visner GA. Bone marrow stem cells as a vehicle for delivery of heme oxygenase-1 gene. Stem Cells Dev. 2006;15:79\u201386.","journal-title":"Stem Cells Dev"},{"key":"427_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13287-015-0178-y","volume":"6","author":"MW Lee","year":"2015","unstructured":"Lee MW, Ryu S, Kim DS, Sung KW, Koo HH, Yoo KH. Strategies to improve the immunosuppressive properties of human mesenchymal stem cells. Stem Cell Res Ther. 2015;6:179.","journal-title":"Stem Cell Res Ther"},{"key":"427_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jcmm.12482","volume":"19","author":"WH Liu","year":"2015","unstructured":"Liu WH, Song FQ, Ren LN, Guo WQ, Wang T, Feng YX, Feng YX, Tang LJ, Li K. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015;19:511\u201320.","journal-title":"J Cell Mol Med"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/jcmm.12414","volume":"19","author":"X L\u00e9v\u00eaque","year":"2015","unstructured":"L\u00e9v\u00eaque X, Mathieux E, Nerri\u00e8re-Daguin V, Thinard R, Kermarrec L, Durand T, Haudebourg T, Vanhove B, Lescaudron L, Neveu I, Naveilhan P. Local control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantation. J Cell Mol Med. 2015;19:124\u201334.","journal-title":"J Cell Mol Med"},{"key":"427_CR18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringd\u00e9n O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579\u201386.","journal-title":"Lancet"},{"key":"427_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP, Roelen DL, van Kooten C, Fibbe WE, Rabelink TJ. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013;2:107\u201311.","journal-title":"Stem Cells Transl Med"},{"key":"427_CR20","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/jcmm.12424","volume":"18","author":"X Li","year":"2014","unstructured":"Li X, Xiao Y, Cui Y, Tan T, Narasimhulu CA, Hao H, Liu L, Zhang J, He G, Verfaillie CM, Lei M, Parthasarathy S, Ma J, Zhu H, Liu Z. Cell membrane damage is involved in the impaired survival of bone marrow stem cells by oxidized low-density lipoprotein. J Cell Mol Med. 2014;18:2445\u201353.","journal-title":"J Cell Mol Med"},{"key":"427_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/hc0102.101442","volume":"105","author":"C Toma","year":"2002","unstructured":"Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93\u20138.","journal-title":"Circulation"},{"key":"427_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1006\/jmcc.2001.1367","volume":"33","author":"M Zhang","year":"2001","unstructured":"Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33:907\u201321.","journal-title":"J Mol Cell Cardiol"},{"key":"427_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1634\/stemcells.2005-0121","volume":"24","author":"W Zhu","year":"2006","unstructured":"Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells. 2006;24:416\u201325.","journal-title":"Stem Cells"},{"key":"427_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12:87\u2013117.","journal-title":"Annu Rev Biomed Eng"},{"key":"427_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1517\/14712590903213651","volume":"9","author":"JW Lee","year":"2009","unstructured":"Lee JW, Gupta N, Serikov V, Matthay MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther. 2009;9:1259\u201370.","journal-title":"Expert Opin Biol Ther"},{"key":"427_CR26","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1096\/fasebj.2.10.3290025","volume":"2","author":"MD Maines","year":"1988","unstructured":"Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557\u201368.","journal-title":"FASEB J"},{"key":"427_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1084\/jem.192.7.1015","volume":"192","author":"S Brouard","year":"2000","unstructured":"Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med. 2000;192:1015\u201326.","journal-title":"J Exp Med"},{"key":"427_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1164\/rccm.200311-1607OC","volume":"170","author":"H Zhou","year":"2004","unstructured":"Zhou H, Lu F, Latham C, Zander DS, Visner GA. Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro. Am J Respir Crit Care Med. 2004;170:633\u201340.","journal-title":"Am J Respir Crit Care Med"},{"key":"427_CR29","doi-asserted-by":"publisher","first-page":"H1320","DOI":"10.1152\/ajpheart.01330.2008","volume":"298","author":"T Tsubokawa","year":"2010","unstructured":"Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri MA, Ishibashi-Ueda H, Nagaya N, Yamagishi M. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol. 2010;298:H1320\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"427_CR30","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1182\/blood-2005-02-0494","volume":"106","author":"C Chauveau","year":"2005","unstructured":"Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, Anegon I. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood. 2005;106:1694\u2013702.","journal-title":"Blood"},{"key":"427_CR31","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood-2007-02-075481","volume":"110","author":"D Chabannes","year":"2007","unstructured":"Chabannes D, Hill M, Merieau E, Rossignol J, Brion R, Soulillou JP, Anegon I, Cuturi MC. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood. 2007;110:3691\u20134.","journal-title":"Blood"},{"key":"427_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.gt.3302208","volume":"11","author":"C Braudeau","year":"2004","unstructured":"Braudeau C, Bouchet D, Tesson L, Iyer S, Remy S, Buelow R, Anegon I, Chauveau C. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 2004;11:701\u201310.","journal-title":"Gene Ther"},{"key":"427_CR33","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.3748\/wjg.v19.i23.3583","volume":"19","author":"ZY Shen","year":"2013","unstructured":"Shen ZY, Zhang J, Song HL, Zheng WP. Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption via a TNF-alpha-regulated mechanism. World J Gastroenterol. 2013;19:3583\u201395.","journal-title":"World J Gastroenterol"},{"key":"427_CR34","doi-asserted-by":"publisher","first-page":"e114528","DOI":"10.1371\/journal.pone.0114528","volume":"9","author":"Y Yang","year":"2014","unstructured":"Yang Y, Song HL, Zhang W, Wu BJ, Fu NN, Zheng WP, Dong C, Shen ZY. Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation. PLoS One. 2014;9:e114528.","journal-title":"PLoS One"},{"key":"427_CR35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/01.TP.0000062840.49159.2F","volume":"75","author":"T Wu","year":"2003","unstructured":"Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ. A schema for histologic grading of small intestine allograft acute rejection. Transplantation. 2003;75:1241\u20138.","journal-title":"Transplantation"},{"key":"427_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/cmi.2012.41","volume":"9","author":"H Liu","year":"2012","unstructured":"Liu H, Zhang C, Liang T, Song J, Hao J, Hou G. Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway. Cell Mol Immunol. 2012;9:503\u201310.","journal-title":"Cell Mol Immunol"},{"key":"427_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jss.2003.12.028","volume":"119","author":"TM Fishbein","year":"2004","unstructured":"Fishbein TM, Liu J, Wang L, Li Y, Boros P. Increased apoptosis is specific for acute rejection in rat small bowel transplant. J Surg Res. 2004;119:51\u20135.","journal-title":"J Surg Res"},{"key":"427_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/MOT.0b013e3283398fa4","volume":"5","author":"IG Tzvetanov","year":"2010","unstructured":"Tzvetanov IG, Oberholzer J, Benedetti E. Current status of living donor small bowel transplantation. Curr Opin Organ Transplant. 2010;5:346\u20138.","journal-title":"Curr Opin Organ Transplant"},{"key":"427_CR39","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/tri.12132","volume":"26","author":"N Perico","year":"2013","unstructured":"Perico N, Casiraghi F, Gotti E, Introna M, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Noris M, Remuzzi G. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Transpl Int. 2013;26:867\u201378.","journal-title":"Transpl Int"},{"key":"427_CR40","doi-asserted-by":"publisher","first-page":"e73526","DOI":"10.1371\/journal.pone.0073526","volume":"8","author":"M Perez-Basterrechea","year":"2013","unstructured":"Perez-Basterrechea M, Obaya AJ, Meana A, Otero J, Esteban MM. Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation. PLoS One. 2013;8:e73526.","journal-title":"PLoS One"},{"key":"427_CR41","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/mt.2013.147","volume":"21","author":"H Wu","year":"2013","unstructured":"Wu H, Wen D, Mahato RI. Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. Mol Ther. 2013;21:1778\u201386.","journal-title":"Mol Ther"},{"key":"427_CR42","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.3748\/wjg.v20.i25.8215","volume":"20","author":"SM Dogan","year":"2014","unstructured":"Dogan SM, Kilinc S, Kebapci E, Tugmen C, Gurkan A, Baran M, Kurtulmu\u015f Y, Olmez M, Karaca C. Mesenchymal stem cell therapy in patients with small bowel transplantation: single center experience. World J Gastroenterol. 2014;20:8215\u201320.","journal-title":"World J Gastroenterol"},{"key":"427_CR43","doi-asserted-by":"publisher","first-page":"e77591","DOI":"10.1371\/journal.pone.0077591","volume":"8","author":"V Mundra","year":"2013","unstructured":"Mundra V, Wu H, Mahato RI. Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation. PLoS One. 2013;8:e77591.","journal-title":"PLoS One"},{"key":"427_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/cei.12283","volume":"176","author":"J Niu","year":"2014","unstructured":"Niu J, Yue W, Song Y, Zhang Y, Qi X, Wang Z, Liu B, Shen H, Hu X. Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells. Clin Exp Immunol. 2014;176:473\u201384.","journal-title":"Clin Exp Immunol"},{"key":"427_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12192-011-0298-y","volume":"17","author":"P Hamedi-Asl","year":"2012","unstructured":"Hamedi-Asl P, Halabian R, Bahmani P, Mohammadipour M, Mohammadzadeh M, Roushandeh AM, Jahanian-Najafabadi A, Kuwahara Y, Roudkenar MH. Adenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses. Cell Stress Chaperones. 2012;17:181\u201390.","journal-title":"Cell Stress Chaperones"},{"key":"427_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/scrt408","volume":"5","author":"Y Li","year":"2014","unstructured":"Li Y, Yan M, Yang J, Raman I, Du Y, Min S, Fang X, Mohan C, Li QZ. Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation. Stem Cell Res Ther. 2014;5:19.","journal-title":"Stem Cell Res Ther"},{"key":"427_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13287-015-0224-9","volume":"6","author":"S Sen","year":"2015","unstructured":"Sen S, Domingues CC, Rouphael C, Chou C, Kim C, Yadava N. Genetic modification of human mesenchymal stem cells helps to reduce adiposity and improve glucose tolerance in an obese diabetic mouse model. Stem Cell Res Ther. 2015;6:242.","journal-title":"Stem Cell Res Ther"},{"key":"427_CR48","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2174\/1566524011313050016","volume":"13","author":"J Stagg","year":"2013","unstructured":"Stagg J, Galipeau J. Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr Mol Med. 2013;13:856\u201367.","journal-title":"Curr Mol Med"},{"key":"427_CR49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MOT.0000000000000075","volume":"19","author":"P Ruiz","year":"2014","unstructured":"Ruiz P. Updates on acute and chronic rejection in small bowel and multivisceral allografts. Curr Opin Organ Transplant. 2014;19:293\u2013302.","journal-title":"Curr Opin Organ Transplant"},{"key":"427_CR50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0952-7915(98)80219-7","volume":"10","author":"JO Manilay","year":"1998","unstructured":"Manilay JO, Sykes M. Natural killer cells and their role in graft rejection. Curr Opin Immunol. 1998;10:532\u20138.","journal-title":"Curr Opin Immunol"},{"key":"427_CR51","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.4049\/jimmunol.180.12.7818","volume":"180","author":"A Kroemer","year":"2008","unstructured":"Kroemer A, Xiao X, Degauque N, Edtinger K, Wei H, Demirci G, Li XC. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol. 2008;180:7818\u201326.","journal-title":"J Immunol"},{"key":"427_CR52","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.transproceed.2008.08.014","volume":"40","author":"Y Chen","year":"2008","unstructured":"Chen Y, Chen J, Liu Z, Liang S, Luan X, Long F, et al. Relationship between Th1\/Th2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc. 2008;40:2691\u20135.","journal-title":"Transplant Proc"},{"key":"427_CR53","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.transproceed.2013.01.069","volume":"45","author":"W Liao","year":"2013","unstructured":"Liao W, Zeng F, Kang K, Qi Y, Yao L, Yang H, et al. Lipoxin A4 attenuates acute rejection via shifting TH1\/TH2 cytokine balance in rat liver transplantation. Transplant Proc. 2013;45:2451\u20134.","journal-title":"Transplant Proc"},{"key":"427_CR54","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3892\/mmr.2014.2073","volume":"9","author":"B Li","year":"2014","unstructured":"Li B, Tian L, Diao Y, Li X, Zhao L, Wang X. Exogenous IL-10 induces corneal transplantation immune tolerance by a mechanism associated with the altered Th1\/Th2 cytokine ratio and the increased expression of TGF-\u03b2. Mol Med Rep. 2014;9:2245\u201350.","journal-title":"Mol Med Rep"},{"issue":"Suppl 1","key":"427_CR55","doi-asserted-by":"publisher","first-page":"S623","DOI":"10.1111\/j.1432-2277.1994.tb01458.x","volume":"7","author":"N van Emmerik","year":"1994","unstructured":"van Emmerik N, Baan C, Vaessen L, Jutte N, Quint W, Balk A, Bos E, Niesters H, Weimar W. Cytokine gene expression profiles in human endomyocardial biopsy (EMB) derived lymphocyte cultures and in EMB tissue. Transpl Int. 1994;7 Suppl 1:S623\u20136.","journal-title":"Transpl Int"},{"key":"427_CR56","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.4049\/jimmunol.165.9.4848","volume":"165","author":"F Cottrez","year":"2000","unstructured":"Cottrez F, Hurst SD, Coffman RL, Groux H. gulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol. 2000;165:4848\u201353.","journal-title":"J Immunol"},{"key":"427_CR57","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00007890-199810150-00013","volume":"66","author":"R Josien","year":"1998","unstructured":"Josien R, Muschen M, Gilbert E, Douillard P, Heslan JM, Soulillou JP, Cuturi MC. Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation. 1998;66:887\u201393.","journal-title":"Transplantation"},{"key":"427_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1034\/j.1600-6143.2002.020104.x","volume":"2","author":"AB Adams","year":"2002","unstructured":"Adams AB, Larsen CP, Pearson TC, Pearson TC, Newell KA. The role of TNF receptor and TNF superfamily molecules in organ transplantation. Am J Transplant. 2002;2:12\u20138.","journal-title":"Am J Transplant"},{"key":"427_CR59","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.dld.2012.08.002","volume":"44","author":"A Hu","year":"2012","unstructured":"Hu A, Li Q, Shi H, Tai Q, Wu L, Xiong J, Fu B, He X. Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1\/Th2 balance in rat heterotopic small bowel transplantation. Dig Liver Dis. 2012;44:988\u201394.","journal-title":"Dig Liver Dis"},{"key":"427_CR60","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0966-3274(00)00027-7","volume":"8","author":"MC Wiggins","year":"2000","unstructured":"Wiggins MC, Bracher M, Mall A, Hickman R, Robson SC, Kahn D. Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients. Transpl Immunol. 2000;8:211\u20135.","journal-title":"Transpl Immunol"},{"key":"427_CR61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2010.22","volume":"7","author":"S Leung","year":"2010","unstructured":"Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol. 2010;7:182\u20139.","journal-title":"Cell Mol Immunol"},{"key":"427_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","volume":"30","author":"YK Lee","year":"2009","unstructured":"Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, Weaver CT. Late developmental plasticity in the T helper 17 lineage. Immunity. 2009;30:92\u2013107.","journal-title":"Immunity"},{"key":"427_CR63","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821\u201352.","journal-title":"Annu Rev Immunol"},{"key":"427_CR64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"427_CR65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235\u20138.","journal-title":"Nature"},{"key":"427_CR66","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910\u20134.","journal-title":"J Biol Chem"},{"key":"427_CR67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","volume":"2","author":"EM Shevach","year":"2002","unstructured":"Shevach EM. CD4\u2009+\u2009CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002;2:389\u2013400.","journal-title":"Nat Rev Immunol"},{"key":"427_CR68","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1096\/fj.07-8472com","volume":"1","author":"SS Lee","year":"2007","unstructured":"Lee SS, Gao W, Mazzola S, Thomas MN, Csizmadia E, Otterbein LE, Bach FH, Wang H. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J. 2007;1:3450\u20137.","journal-title":"FASEB J"},{"key":"427_CR69","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.172.11.6539","volume":"172","author":"MK Lee","year":"2004","unstructured":"Lee MK, Moore DJ, Jarrett BP, Lian MM, Deng S, Huang X, Markmann JW, Chiaccio M, Barker CF, Caton AJ, Markmann JF. Promotion of allograft survival by CD4\u2009+\u2009CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol. 2004;172:6539\u201344.","journal-title":"J Immunol"},{"key":"427_CR70","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/01.TP.0000155179.61445.78","volume":"79","author":"FS Benghiat","year":"2005","unstructured":"Benghiat FS, Graca L, Braun MY, Detienne S, Moore F, Buonocore S, Flamand V, Waldmann H, Goldman M, Le Moine A. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation. 2005;79:648\u201354.","journal-title":"Transplantation"},{"key":"427_CR71","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/01.TP.0000159870.01567.02","volume":"79","author":"S Koksoy","year":"2005","unstructured":"Koksoy S, Elpek KG, Yolcu ES, Shirwan H. Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4\u2009+\u2009CD25+ Treg cells. Transplantation. 2005;79:1492\u20137.","journal-title":"Transplantation"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0427-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-016-0427-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-016-0427-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:24:23Z","timestamp":1637043863000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-016-0427-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,20]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s13287-016-0427-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,20]]},"assertion":[{"value":"3 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"164"}}